Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$697.0K
34.78K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 34.78K shares of AVALO THERAPEUTICS, INC. valued at approximately $697.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001950047-26-008317
Officer· Interim CFO
Since Apr 2020
34.78K
Shares to sell
$697.0K
Approx. market value
31.03K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Options Under a Registered Plan
Services Rendered
8/18/2026
25.12KExercise of Options Under a Registered Plan
Services Rendered
8/18/2026
5.91KTotal acquired31.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/18/2026 | Exercise of Options Under a Registered Plan Services Rendered | 25.12K | — |
8/18/2026 | Exercise of Options Under a Registered Plan Services Rendered | 5.91K | — |
| Total | 31.03K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.75K
Market value
$74.8K
8/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
31.03K
Market value
$622.2K
8/18/2026
Total
Units
34.78K
Value
$697.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/17/2026 | 3.75K | $74.8K | — | Completed |
| Planned — Approximate Date | ||||
8/18/2026 | 31.03K | $622.2K | NASDAQ | Planned |
| Total | 34.78K | $697.0K | ||